Literature DB >> 19004957

Conformational changes in the solution structure of the dengue virus 5' end in the presence and absence of the 3' untranslated region.

Charlotta Polacek1, Jonathan E Foley, Eva Harris.   

Abstract

Dengue virus (DENV) is an approximately 10.7-kb positive-sense RNA virus that circularizes via RNA-RNA interactions between sequences in the 5' and 3' terminal regions. Complementarity between the cyclization sequence (CS) and the upstream AUG region (UAR) has been shown to be necessary for viral replication. Here, we present the solution structure of the 5' end of DENV type 2 in the presence and absence of the 3' end. We demonstrate that hybridization between the 5' and 3' CSs is independent of the UAR while the 5' UAR-3' UAR hybridization is dependent upon the 5' CS-3' CS interaction.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19004957      PMCID: PMC2612390          DOI: 10.1128/JVI.01362-08

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  In vitro RNA synthesis from exogenous dengue viral RNA templates requires long range interactions between 5'- and 3'-terminal regions that influence RNA structure.

Authors:  S You; B Falgout; L Markoff; R Padmanabhan
Journal:  J Biol Chem       Date:  2001-02-05       Impact factor: 5.157

2.  Conserved RNA secondary structures in Flaviviridae genomes.

Authors:  Caroline Thurner; Christina Witwer; Ivo L Hofacker; Peter F Stadler
Journal:  J Gen Virol       Date:  2004-05       Impact factor: 3.891

3.  Sequence and secondary structure analysis of the 5'-terminal region of flavivirus genome RNA.

Authors:  M A Brinton; J H Dispoto
Journal:  Virology       Date:  1988-02       Impact factor: 3.616

4.  Functional analysis of dengue virus cyclization sequences located at the 5' and 3'UTRs.

Authors:  Diego E Alvarez; Claudia V Filomatori; Andrea V Gamarnik
Journal:  Virology       Date:  2008-03-04       Impact factor: 3.616

5.  Conserved elements in the 3' untranslated region of flavivirus RNAs and potential cyclization sequences.

Authors:  C S Hahn; Y S Hahn; C M Rice; E Lee; L Dalgarno; E G Strauss; J H Strauss
Journal:  J Mol Biol       Date:  1987-11-05       Impact factor: 5.469

6.  A different approach to RNA sequencing.

Authors:  J Stanley; S Vassilenko
Journal:  Nature       Date:  1978-07-06       Impact factor: 49.962

7.  A novel in vitro replication system for Dengue virus. Initiation of RNA synthesis at the 3'-end of exogenous viral RNA templates requires 5'- and 3'-terminal complementary sequence motifs of the viral RNA.

Authors:  S You; R Padmanabhan
Journal:  J Biol Chem       Date:  1999-11-19       Impact factor: 5.157

8.  Terminal structures of West Nile virus genomic RNA and their interactions with viral NS5 protein.

Authors:  Hongping Dong; Bo Zhang; Pei-Yong Shi
Journal:  Virology       Date:  2008-09-16       Impact factor: 3.616

9.  Co-selection of West Nile virus nucleotides that confer resistance to an antisense oligomer while maintaining long-distance RNA/RNA base pairings.

Authors:  Bo Zhang; Hongping Dong; David A Stein; Pei-Yong Shi
Journal:  Virology       Date:  2008-10-07       Impact factor: 3.616

10.  West Nile virus genome cyclization and RNA replication require two pairs of long-distance RNA interactions.

Authors:  Bo Zhang; Hongping Dong; David A Stein; Patrick L Iversen; Pei-Yong Shi
Journal:  Virology       Date:  2008-02-06       Impact factor: 3.616

View more
  31 in total

1.  Identification of cis-acting elements in the 3'-untranslated region of the dengue virus type 2 RNA that modulate translation and replication.

Authors:  Mark Manzano; Erin D Reichert; Stephanie Polo; Barry Falgout; Wojciech Kasprzak; Bruce A Shapiro; Radhakrishnan Padmanabhan
Journal:  J Biol Chem       Date:  2011-04-22       Impact factor: 5.157

2.  Composition of the sequence downstream of the dengue virus 5' cyclization sequence (dCS) affects viral RNA replication.

Authors:  Peter Friebe; José Peña; Marie O F Pohl; Eva Harris
Journal:  Virology       Date:  2011-12-01       Impact factor: 3.616

3.  Circularization of the HIV-1 genome facilitates strand transfer during reverse transcription.

Authors:  Nancy Beerens; Jørgen Kjems
Journal:  RNA       Date:  2010-04-29       Impact factor: 4.942

4.  The 5' and 3' downstream AUG region elements are required for mosquito-borne flavivirus RNA replication.

Authors:  Peter Friebe; Pei-Yong Shi; Eva Harris
Journal:  J Virol       Date:  2010-12-01       Impact factor: 5.103

5.  A balance between circular and linear forms of the dengue virus genome is crucial for viral replication.

Authors:  Sergio M Villordo; Diego E Alvarez; Andrea V Gamarnik
Journal:  RNA       Date:  2010-10-27       Impact factor: 4.942

6.  Quantitative mass spectrometry of DENV-2 RNA-interacting proteins reveals that the DEAD-box RNA helicase DDX6 binds the DB1 and DB2 3' UTR structures.

Authors:  Alex Michael Ward; Katell Bidet; Ang Yinglin; Siok Ghee Ler; Kelly Hogue; Walter Blackstock; Jayantha Gunaratne; Mariano A Garcia-Blanco
Journal:  RNA Biol       Date:  2011-11-01       Impact factor: 4.652

7.  RNA sequences and structures required for the recruitment and activity of the dengue virus polymerase.

Authors:  Claudia V Filomatori; Nestor G Iglesias; Sergio M Villordo; Diego E Alvarez; Andrea V Gamarnik
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

8.  Interplay of RNA elements in the dengue virus 5' and 3' ends required for viral RNA replication.

Authors:  Peter Friebe; Eva Harris
Journal:  J Virol       Date:  2010-03-31       Impact factor: 5.103

9.  Conserved and variable structural elements in the 5' untranslated region of two hypoviruses from the filamentous fungus Cryphonectria parasitica.

Authors:  Rong Mu; Tammy A Romero; Kathryn A Hanley; Angus L Dawe
Journal:  Virus Res       Date:  2011-08-22       Impact factor: 3.303

10.  A long-range RNA-RNA interaction between the 5' and 3' ends of the HCV genome.

Authors:  Cristina Romero-López; Alfredo Berzal-Herranz
Journal:  RNA       Date:  2009-07-15       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.